Related Experiment Videos
The management of perioperative bleeding
1Department of Haematology, Guy's and St. Thomas' Trust, London, UK.
Blood Reviews
|June 24, 2003
Summary
Excess perioperative bleeding, a major surgical risk, stems from various factors including bleeding disorders and coagulation issues. Strategies focus on identifying at-risk patients and improving hemostasis management to reduce blood transfusions.
Area of Science:
- Anesthesiology
- Hematology
- Surgical Sciences
Background:
- Excessive perioperative bleeding is a significant surgical complication, increasing patient morbidity and mortality.
- Causes include pre-existing bleeding disorders, operative factors, and coagulation abnormalities from blood loss.
- Complex surgeries like cardiopulmonary bypass and liver transplantation present unique hemostatic challenges.
Purpose of the Study:
- To highlight the importance of identifying patients at risk for excessive perioperative bleeding.
- To emphasize understanding perioperative hemostatic changes for improved management strategies.
- To discuss current and emerging pharmacological and diagnostic interventions.
Main Methods:
- Review of causes and contributing factors to perioperative bleeding.
- Discussion of hemostatic changes during complex surgical procedures.
- Evaluation of pharmacological interventions (aprotinin, tranexamic acid, desmopressin, recombinant VIIa).
- Assessment of near-patient testing (thromboelastography, platelet function analyzers).
Main Results:
- Perioperative bleeding is multifactorial, often involving a combination of pathologies.
- Near-patient testing allows for detailed assessment of hemostasis.
- Pharmacological agents are used for prophylaxis and treatment of bleeding.
- A primary goal is reducing allogeneic blood transfusions.
Conclusions:
- Effective management of perioperative bleeding requires identifying at-risk patients and understanding hemostatic dynamics.
- Advanced diagnostic tools and targeted pharmacological interventions are crucial.
- Reducing allogeneic blood transfusions remains a key objective in perioperative care.